A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF- β1-Induced EMT < b > < i > in Vivo < /i > < /b > and < b > < i > in Vitro < /i > < /b >

Conclusion: This MyD88 inhibitor may be a potential therapeutic agent to ameliorate RIF.Kidney Blood Press Res 2018;43:1677 –1687
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research